These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 14694248

  • 1. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis.
    Kiely JL, Nolan P, McNicholas WT.
    Thorax; 2004 Jan; 59(1):50-5. PubMed ID: 14694248
    [Abstract] [Full Text] [Related]

  • 2. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J, Caldwell MF, Wolthers OD.
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [Abstract] [Full Text] [Related]

  • 3. Effect of topical corticosteroids on allergic airway inflammation and disease severity in obstructive sleep apnoea.
    Lavigne F, Petrof BJ, Johnson JR, Lavigne P, Binothman N, Kassissia GO, Al Samri M, Giordano C, Dubé N, Hercz D, Benedetti A, Hamid Q.
    Clin Exp Allergy; 2013 Oct; 43(10):1124-33. PubMed ID: 24074330
    [Abstract] [Full Text] [Related]

  • 4. Allergic and nonallergic rhinitis: the threat for obstructive sleep apnea.
    Kalpaklioğlu AF, Kavut AB, Ekici M.
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):20-5. PubMed ID: 19663122
    [Abstract] [Full Text] [Related]

  • 5. [Effect of salmeterol in obstructive sleep apnea syndrome].
    Rasche K, Duchna HW, Orth M, Bauer TT, Lauer J, Podbregar D, Schultze-Werninghaus G.
    Pneumologie; 1998 Jan; 52(1):11-3. PubMed ID: 9540364
    [Abstract] [Full Text] [Related]

  • 6. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
    Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea.
    Brouillette RT, Manoukian JJ, Ducharme FM, Oudjhane K, Earle LG, Ladan S, Morielli A.
    J Pediatr; 2001 Jun; 138(6):838-44. PubMed ID: 11391326
    [Abstract] [Full Text] [Related]

  • 8. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
    Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, Rickard KA.
    Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
    [Abstract] [Full Text] [Related]

  • 9. Disorders of glucose metabolism and insulin resistance in patients with obstructive sleep apnoea syndrome.
    Bulcun E, Ekici M, Ekici A.
    Int J Clin Pract; 2012 Jan; 66(1):91-7. PubMed ID: 22171909
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of multilevel (tongue and palate) radiofrequency tissue ablation for patients with obstructive sleep apnea syndrome.
    Steward DL.
    Laryngoscope; 2004 Dec; 114(12):2073-84. PubMed ID: 15564825
    [Abstract] [Full Text] [Related]

  • 11. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
    Parameswaran K, Fanat A, O'Byrne PM.
    Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
    [Abstract] [Full Text] [Related]

  • 12. Nasal corticosteroids for children with snoring.
    Alexopoulos EI, Kaditis AG, Kalampouka E, Kostadima E, Angelopoulos NV, Mikraki V, Skenteris N, Gourgoulianis K.
    Pediatr Pulmonol; 2004 Aug; 38(2):161-7. PubMed ID: 15211701
    [Abstract] [Full Text] [Related]

  • 13. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome.
    Sugiura T, Noda A, Nakata S, Yasuda Y, Soga T, Miyata S, Nakai S, Koike Y.
    Respiration; 2007 Aug; 74(1):56-60. PubMed ID: 16299414
    [Abstract] [Full Text] [Related]

  • 14. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
    Dahl R, Nielsen LP, Kips J, Foresi A, Cauwenberge P, Tudoric N, Howarth P, Richards DH, Williams M, Pauwels R, SPIRA Study Group.
    Allergy; 2005 Jul; 60(7):875-81. PubMed ID: 15932376
    [Abstract] [Full Text] [Related]

  • 15. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 16. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628
    [Abstract] [Full Text] [Related]

  • 17. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
    Khanna P, Shah A.
    Am J Rhinol; 2005 Feb 15; 19(3):316-21. PubMed ID: 16011141
    [Abstract] [Full Text] [Related]

  • 18. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis?
    Craig TJ, Hanks CD, Fisher LH.
    J Allergy Clin Immunol; 2005 Dec 15; 116(6):1264-6. PubMed ID: 16337455
    [Abstract] [Full Text] [Related]

  • 19. The effects of mometasone furoate and desloratadine in obstructive sleep apnea syndrome patients with allergic rhinitis.
    Acar M, Cingi C, Sakallioglu O, San T, Fatih Yimenicioglu M, Bal C.
    Am J Rhinol Allergy; 2013 Dec 15; 27(4):e113-6. PubMed ID: 23883803
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy of nasal drop and nasal spray applications of fluticasone propionate in nasal polyps.
    Demirel T, Orhan KS, Keleş N, Değer K.
    Kulak Burun Bogaz Ihtis Derg; 2008 Dec 15; 18(1):1-6. PubMed ID: 18443395
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.